Biofire Respiratory Panel 2.1
Device Diagnostics
PDI 00815381020529
General payments
$86,940
Research payments
$113,012
Through program year 2025, $86,940 in general payments and $113,012 in research payments were reported against Biofire Respiratory Panel 2.1 (Diagnostics).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $10,598 | 31 |
| 2024 | General | $2,030 | 3 |
| 2024 | Research | $5,147 | 5 |
| 2023 | General | $74,312 | 87 |
| 2023 | Research | $107,865 | 3 |
Breakdown
The top 5 of 24 recipients; each share is of general payments naming this product in 2025.
The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
121 general · 8 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.